Dr. Reuben was charged with submitting fabricated research in a 2007 pain management study of patients who had knee surgery. The test, funded by a $73,000 research grant, was supposed to measure the effects of the drug Celebrex on reducing post-operative pain.
A 2008 routine audit by Baystate revealed the test was never conducted, even though Dr. Reuben had published studies suggesting otherwise. After further investigation, the hospital discovered Dr. Reuben had misrepresented findings in 21 other studies dating back to 1996.
Dr. Reuben lost his medical license and has been banned from conducting drug research.
Read more about Dr. Reuben’s sentencing.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
